Luis Calvo

Showing 1-5 of 5 articles

Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry

Salinas P, Galeote G, Martin-Reyes R, Pérez-Vizcayno M, Hernández-Antolín R, Mainar V, Moreu J, de la Torre Hernandez J, Zueco J, Tello A, Jiménez-Valero S, Sanchez Recalde A, Calvo L, Plaza I, Alfonso F, Mariscal F, de Sa E, Macaya C, López-Sendón J-L, Moreno R

April 20, 2011

Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents

Moreno R, Jiménez-Valero S, Sanchez Recalde A, Galeote G, Calvo L, Martin-Reyes R, Sabaté M, Plaza I, Macaya C, López-Sendón J-L

March 21, 2011

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial

Moreno R, Garcia E, Teles R, Almeida M, Carvalho H, Sabaté M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Pérez de Prado A, Martin-Yuste V, Jiménez-Valero S, Sanchez Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L

May 25, 2010

Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis

Sanchez Recalde A, Valero S, Moreno R, Barreales L, Lozano I, Galeote G, Reyes R, Calvo L, López-Sendón J-L

May 25, 2010

Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents

Rivero F, Moreno R, Barreales L, Galeote G, Sanchez Recalde A, Calvo L, Jiménez-Valero S, Villate A, Vanegas M, López-Sendón J-L

May 13, 2008

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: DLMC in CTO-PCI, Membranous Septum Morphology and TAVI ...

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease